Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Summary

Randomized, double-blind, parallel-group, multicenter study to assess efficacy, safety, and tolerability of oral tropifexor \& licogliflozin combination therapy and each monotherapy, compared with placebo for treatment of adult patients with nonalcoholic steatohepatitis (NASH) and liver fibrosis.

Timeline

Start

2019-12-30

Primary completion

2022-10-27

Completion

2022-10-27

Outcome

Outcome not reported

Stopped (Business): “The sponsor made a business decision to stop development of the trial drugs. The decision to stop the trial early was not because of any safety concerns.”

Drugs

Indications